Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Metrics to compare | AMIX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAMIXPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.3x | −2.9x | −0.5x | |
PEG Ratio | −0.01 | −0.12 | 0.00 | |
Price/Book | 0.4x | 2.3x | 2.6x | |
Price / LTM Sales | - | 3.3x | 3.3x | |
Upside (Analyst Target) | - | 22.1% | 43.5% | |
Fair Value Upside | Unlock | 9.4% | 6.9% | Unlock |